The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Alimta-Global Market Insights and Sales Trends 2025
Synopsis
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
The global Alimta market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alimta in various end use industries. The expanding demands from the Pleural Mesothelioma and Non-small Cell Lung Cancer, are propelling Alimta market. 100mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 500mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Alimta market, driven by demand from China, the second largest economy with some signs of stabilising, the Alimta market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alimta, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alimta market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alimta market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alimta sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alimta covered in this report include Eli Lilly, Abbott Healthcare, Cadila Healthcare and Eagle Pharmaceuticals, etc.
The global Alimta market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Abbott Healthcare
Cadila Healthcare
Eagle Pharmaceuticals
Global Alimta market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alimta market, Segment by Type:
100mg
500mg
Global Alimta market, by Application
Pleural Mesothelioma
Non-small Cell Lung Cancer
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Alimta manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
The global Alimta market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alimta in various end use industries. The expanding demands from the Pleural Mesothelioma and Non-small Cell Lung Cancer, are propelling Alimta market. 100mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 500mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Alimta market, driven by demand from China, the second largest economy with some signs of stabilising, the Alimta market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alimta, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alimta market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alimta market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alimta sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alimta covered in this report include Eli Lilly, Abbott Healthcare, Cadila Healthcare and Eagle Pharmaceuticals, etc.
The global Alimta market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Abbott Healthcare
Cadila Healthcare
Eagle Pharmaceuticals
Global Alimta market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alimta market, Segment by Type:
100mg
500mg
Global Alimta market, by Application
Pleural Mesothelioma
Non-small Cell Lung Cancer
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Alimta manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Alimta Market Overview
1.1 Alimta Product Overview
1.2 Alimta Market Segment by Type
1.2.1 100mg
1.2.2 500mg
1.3 Global Alimta Market Size by Type
1.3.1 Global Alimta Market Size Overview by Type (2018-2029)
1.3.2 Global Alimta Historic Market Size Review by Type (2018-2023)
1.3.3 Global Alimta Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Alimta Sales Breakdown by Type (2018-2023)
1.4.2 Europe Alimta Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Alimta Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Alimta Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Alimta Sales Breakdown by Type (2018-2023)
2 Global Alimta Market Competition by Company
2.1 Global Top Players by Alimta Sales (2018-2023)
2.2 Global Top Players by Alimta Revenue (2018-2023)
2.3 Global Top Players by Alimta Price (2018-2023)
2.4 Global Top Manufacturers Alimta Manufacturing Base Distribution, Sales Area, Product Type
2.5 Alimta Market Competitive Situation and Trends
2.5.1 Alimta Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Alimta Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alimta as of 2022)
2.7 Date of Key Manufacturers Enter into Alimta Market
2.8 Key Manufacturers Alimta Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Alimta Status and Outlook by Region
3.1 Global Alimta Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Alimta Historic Market Size by Region
3.2.1 Global Alimta Sales in Volume by Region (2018-2023)
3.2.2 Global Alimta Sales in Value by Region (2018-2023)
3.2.3 Global Alimta Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Alimta Forecasted Market Size by Region
3.3.1 Global Alimta Sales in Volume by Region (2024-2029)
3.3.2 Global Alimta Sales in Value by Region (2024-2029)
3.3.3 Global Alimta Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Alimta by Application
4.1 Alimta Market Segment by Application
4.1.1 Pleural Mesothelioma
4.1.2 Non-small Cell Lung Cancer
4.2 Global Alimta Market Size by Application
4.2.1 Global Alimta Market Size Overview by Application (2018-2029)
4.2.2 Global Alimta Historic Market Size Review by Application (2018-2023)
4.2.3 Global Alimta Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Alimta Sales Breakdown by Application (2018-2023)
4.3.2 Europe Alimta Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Alimta Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Alimta Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Alimta Sales Breakdown by Application (2018-2023)
5 North America Alimta by Country
5.1 North America Alimta Historic Market Size by Country
5.1.1 North America Alimta Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Alimta Sales in Volume by Country (2018-2023)
5.1.3 North America Alimta Sales in Value by Country (2018-2023)
5.2 North America Alimta Forecasted Market Size by Country
5.2.1 North America Alimta Sales in Volume by Country (2024-2029)
5.2.2 North America Alimta Sales in Value by Country (2024-2029)
6 Europe Alimta by Country
6.1 Europe Alimta Historic Market Size by Country
6.1.1 Europe Alimta Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Alimta Sales in Volume by Country (2018-2023)
6.1.3 Europe Alimta Sales in Value by Country (2018-2023)
6.2 Europe Alimta Forecasted Market Size by Country
6.2.1 Europe Alimta Sales in Volume by Country (2024-2029)
6.2.2 Europe Alimta Sales in Value by Country (2024-2029)
7 Asia-Pacific Alimta by Region
7.1 Asia-Pacific Alimta Historic Market Size by Region
7.1.1 Asia-Pacific Alimta Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Alimta Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Alimta Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Alimta Forecasted Market Size by Region
7.2.1 Asia-Pacific Alimta Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Alimta Sales in Value by Region (2024-2029)
8 Latin America Alimta by Country
8.1 Latin America Alimta Historic Market Size by Country
8.1.1 Latin America Alimta Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Alimta Sales in Volume by Country (2018-2023)
8.1.3 Latin America Alimta Sales in Value by Country (2018-2023)
8.2 Latin America Alimta Forecasted Market Size by Country
8.2.1 Latin America Alimta Sales in Volume by Country (2024-2029)
8.2.2 Latin America Alimta Sales in Value by Country (2024-2029)
9 Middle East and Africa Alimta by Country
9.1 Middle East and Africa Alimta Historic Market Size by Country
9.1.1 Middle East and Africa Alimta Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Alimta Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Alimta Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Alimta Forecasted Market Size by Country
9.2.1 Middle East and Africa Alimta Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Alimta Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Information
10.1.2 Eli Lilly Introduction and Business Overview
10.1.3 Eli Lilly Alimta Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eli Lilly Alimta Products Offered
10.1.5 Eli Lilly Recent Development
10.2 Abbott Healthcare
10.2.1 Abbott Healthcare Company Information
10.2.2 Abbott Healthcare Introduction and Business Overview
10.2.3 Abbott Healthcare Alimta Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Healthcare Alimta Products Offered
10.2.5 Abbott Healthcare Recent Development
10.3 Cadila Healthcare
10.3.1 Cadila Healthcare Company Information
10.3.2 Cadila Healthcare Introduction and Business Overview
10.3.3 Cadila Healthcare Alimta Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cadila Healthcare Alimta Products Offered
10.3.5 Cadila Healthcare Recent Development
10.4 Eagle Pharmaceuticals
10.4.1 Eagle Pharmaceuticals Company Information
10.4.2 Eagle Pharmaceuticals Introduction and Business Overview
10.4.3 Eagle Pharmaceuticals Alimta Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eagle Pharmaceuticals Alimta Products Offered
10.4.5 Eagle Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Alimta Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Alimta Industrial Chain Analysis
11.4 Alimta Market Dynamics
11.4.1 Alimta Industry Trends
11.4.2 Alimta Market Drivers
11.4.3 Alimta Market Challenges
11.4.4 Alimta Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Alimta Distributors
12.3 Alimta Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
